MarketCap
Facebook
X
Telegram
Mustang Bio PEG Ratio | MBIO
Annual PEG Ratio Mustang Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00287 | -0.000067 | -0.000005 | -0.000434 | - | -0.342 | 0.223 | -0.372 | 0.0625 | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.223 | -0.372 | -0.0539 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M |  USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
-5.4 | - | - | $ 5.18 B | USA |
 |
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
-0 | - | 1083.1 % | $ 745 M | USA |
 |
AstraZeneca PLC
AZN
|
0.249 | - | - | $ 96.9 B |  Britain |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | USA |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
EyePoint Pharmaceuticals
EYPT
|
-0 | $ 0.36 | 0.59 % | $ 26.4 K | USA |
 |
Bio-Path Holdings
BPTH
|
-0.00177 | - | - | $ 100 K | USA |
 |
Cara Therapeutics
CARA
|
0.00324 | - | -3.03 % | $ 260 M | USA |
 |
ChromaDex Corporation
CDXC
|
-0.611 | - | -0.88 % | $ 598 M | USA |
 |
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
0 | - | -5.98 % | $ 34.1 M | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
-0.00719 | - | 11.68 % | $ 8.97 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
0.405 | - | -5.68 % | $ 8.28 M | USA |
 |
Enochian Biosciences
ENOB
|
-0.000004 | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
0.799 | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
0.000199 | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
-0.000013 | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
-0.0162 | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
0.168 | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
3.71 | - | - | $ 4.47 B | USA |
 |
Frequency Therapeutics
FREQ
|
-1.47 | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
0.563 | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
-19 | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
0.122 | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
0.0195 | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
-0.156 | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
-0.0736 | $ 10.83 | 10.69 % | $ 1.75 B | USA |
 |
Hepion Pharmaceuticals
HEPA
|
-0.000031 | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
-0.00188 | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
-0.0707 | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-3.51 | - | - | $ 1.45 B | Britain |
 |
KemPharm
KMPH
|
0.0352 | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
-0.00435 | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
0.0152 | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-0.000467 | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
-0.000013 | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-0.00863 | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
-0.000001 | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
-0.000018 | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
-0.000183 | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
-0.00825 | $ 8.55 | -8.85 % | $ 593 M | USA |
|
BiomX
PHGE
|
-0.000755 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-0.00912 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-0.0068 | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
-0.00473 | - | -1.9 % | $ 33.3 M | Israel |